Quinn Opportunity Partners LLC - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 172 filers reported holding AXSOME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
Quinn Opportunity Partners LLC ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$231,000
-51.1%
7,0000.0%0.02%
-48.3%
Q2 2021$472,000
+19.2%
7,0000.0%0.03%
+16.0%
Q1 2021$396,000
-30.5%
7,0000.0%0.02%
-47.9%
Q4 2020$570,000
+14.2%
7,0000.0%0.05%
-9.4%
Q3 2020$499,000
-32.7%
7,000
-22.2%
0.05%
-43.0%
Q2 2020$741,0009,0000.09%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 788,263$35,172,00044.43%
Fairmount Funds Management LLC 1,896,647$84,628,00014.88%
ACT CAPITAL MANAGEMENT, LLC 73,000$3,257,0004.50%
Ghost Tree Capital, LLC 300,000$13,386,0003.76%
Ikarian Capital, LLC 407,600$18,188,0003.62%
Paradigm Biocapital Advisors LP 520,080$23,206,0003.09%
MORGAN JESS S & CO INC 78,895$3,520,0003.06%
PFM Health Sciences, LP 1,659,733$74,057,0002.68%
RTW INVESTMENTS, LP 1,882,164$83,982,0001.94%
Ghost Tree Capital, LLC 150,000$6,693,0001.88%
View complete list of AXSOME THERAPEUTICS INC shareholders